Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Tubulis technologies enable the development of unique ADCs with superior biophysical properties, capable of achieving robust on-tumor payload exposure that can translate to long-lasting anti-tumor activity
Int J Mol Sci 2018;19:3425
The Pennsylvania-based company is supporting the NDA with a clinical development program that consists of 18 studies, including four Phase III trials
10.1021/acs.jproteome.6b00733 11 DAlessandroA.XiaY
I've tried every diet
An editorial published with the new guidelines noted that cost presents a significant barrier to people using these medications
US$ 26.95
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 26.72
US$ 27.59
,type=downsize)
